674 related articles for article (PubMed ID: 3117358)
1. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
2. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
Hori K; Ehrke MJ; Mace K; Maccubbin D; Doyle MJ; Otsuka Y; Mihich E
Cancer Res; 1987 Jun; 47(11):2793-8. PubMed ID: 2882835
[TBL] [Abstract][Full Text] [Related]
4. Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha.
Verstovsek S; Maccubbin D; Ehrke MJ; Mihich E
Cancer Res; 1992 Jul; 52(14):3880-5. PubMed ID: 1617664
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.
Talmadge JE; Tribble HR; Pennington RW; Phillips H; Wiltrout RH
Cancer Res; 1987 May; 47(10):2563-70. PubMed ID: 3105865
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.
Cox GW; Melillo G; Chattopadhyay U; Mullet D; Fertel RH; Varesio L
J Immunol; 1992 Nov; 149(10):3290-6. PubMed ID: 1431106
[TBL] [Abstract][Full Text] [Related]
7. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
Leu RW; Leu NR; Shannon BJ; Fast DJ
J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.
Chen L; Suzuki Y; Wheelock EF
J Immunol; 1987 Dec; 139(12):4096-101. PubMed ID: 3121728
[TBL] [Abstract][Full Text] [Related]
11. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
12. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
Jun CD; Yoon HJ; Kim HM; Chung HT
Biochem Biophys Res Commun; 1995 Jan; 206(3):969-74. PubMed ID: 7832812
[TBL] [Abstract][Full Text] [Related]
15. Preclinical approaches to the treatment of metastatic disease: therapeutic properties of rH TNF, rM IFN-gamma, and rH IL-2.
Talmadge JE; Black PL; Tribble H; Pennington R; Bowersox O; Schneider M; Phillips H
Drugs Exp Clin Res; 1987; 13(6):327-37. PubMed ID: 3115744
[TBL] [Abstract][Full Text] [Related]
16. Taxol provides a second signal for murine macrophage tumoricidal activity.
Manthey CL; Perera PY; Salkowski CA; Vogel SN
J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of macrophage tumoricidal activity by glucocorticoids.
Hogan MM; Vogel SN
J Immunol; 1988 Jan; 140(2):513-9. PubMed ID: 3121748
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
Drapier JC; Wietzerbin J; Hibbs JB
Eur J Immunol; 1988 Oct; 18(10):1587-92. PubMed ID: 3142779
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
Bermudez LE; Young LS
J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
[TBL] [Abstract][Full Text] [Related]
20. Role of tumor necrosis factor in macrophage activation and tumoricidal activity.
Mace KF; Ehrke MJ; Hori K; Maccubbin DL; Mihich E
Cancer Res; 1988 Oct; 48(19):5427-32. PubMed ID: 3416299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
